FDA Warning Letter
A Warning Letter from FDA telling the recipient to also respond to the FTC was held up as an indication of a ‘blurring of the lines between the two agencies’ laws and jurisdictions' by a FDA legal specialist.
Previously FTC and FDA have issued joint letters, as was seen for various swine flu products, but Warning Letter No. 2011-NOL-08 is believed to be the first issued by the US Food and Drug Administration (FDA) that tells the recipient to also respond to the Federal Trade Commission (FTC).
Commenting independently on the warning letter, Ivan Wasserman, a FDA legal specialist and partner at Manatt Phelps & Phillips in Washington, DC, told NutraIngredients-USA.com: "What this indicates is [...] an increasing level of FDA-FTC cooperation and a blurring of the lines between the two agencies’ laws and jurisdictions,” said Wasserman.
To read our coverage, please click here.